3 ASX Penny Stocks With Market Caps Under A$500M

The Australian stock market recently demonstrated resilience, with the ASX climbing above the 7,800 points level despite mixed performances in global markets. In such a landscape, investors often seek out smaller or newer companies that can offer unique growth opportunities. Although "penny stocks" may sound like an outdated term, these stocks represent potential value investments; when backed by strong financials and fundamentals, they can provide significant upside potential.

Advertisement

Top 10 Penny Stocks In Australia

NameShare PriceMarket CapRewards & RisksCTI Logistics (ASX:CLX)A$1.57A$122.48M✅ 4 ⚠️ 2 View Analysis >MotorCycle Holdings (ASX:MTO)A$2.10A$154.99M✅ 4 ⚠️ 2 View Analysis >EZZ Life Science Holdings (ASX:EZZ)A$1.58A$74.53M✅ 4 ⚠️ 2 View Analysis >IVE Group (ASX:IGL)A$2.35A$362.33M✅ 4 ⚠️ 2 View Analysis >GTN (ASX:GTN)A$0.60A$115.38M✅ 3 ⚠️ 2 View Analysis >Bisalloy Steel Group (ASX:BIS)A$3.19A$151.37M✅ 3 ⚠️ 2 View Analysis >Regal Partners (ASX:RPL)A$1.795A$603.41M✅ 4 ⚠️ 3 View Analysis >Sugar Terminals (NSX:SUG)A$1.10A$363.6M✅ 2 ⚠️ 2 View Analysis >NRW Holdings (ASX:NWH)A$2.47A$1.13B✅ 5 ⚠️ 1 View Analysis >LaserBond (ASX:LBL)A$0.3825A$44.88M✅ 3 ⚠️ 2 View Analysis >

Click here to see the full list of 982 stocks from our ASX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Dimerix (ASX:DXB)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Dimerix Limited is a biopharmaceutical company based in Australia that focuses on developing and commercializing pharmaceutical products to address unmet medical needs, with a market cap of A$237.68 million.

Operations: Dimerix generates revenue primarily from its biotechnology segment, amounting to A$0.74 million.

Market Cap: A$237.68M

Dimerix Limited, with a market cap of A$237.68 million, is pre-revenue, generating only A$0.74 million in revenue from its biotechnology segment. The company reported a net loss of A$12.91 million for the half-year ending December 2024, an increase from the prior year. Despite being debt-free and having experienced management and board members, Dimerix faces challenges with less than a year of cash runway if current cash flow trends persist. Its addition to the S&P/ASX All Ordinaries Index reflects some market recognition despite its financial hurdles and high volatility stability over the past year.

ASX:DXB Financial Position Analysis as at Apr 2025
ASX:DXB Financial Position Analysis as at Apr 2025

Sovereign Metals (ASX:SVM)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Sovereign Metals Limited, with a market cap of A$425.91 million, is involved in the exploration and development of mineral resource projects in Malawi.

Operations: Sovereign Metals Limited has not reported any revenue segments.

Market Cap: A$425.91M

Sovereign Metals Limited, with a market cap of A$425.91 million, is pre-revenue and focuses on its Kasiya Rutile Graphite Project in Malawi. The company recently completed a A$40 million equity offering to support ongoing development efforts. Despite being debt-free and having sufficient cash runway for over a year, Sovereign's management team lacks extensive experience with an average tenure of 1.5 years. The board is more seasoned with an average tenure of 6.9 years. Recent geotechnical drilling at Kasiya aims to enhance the project's feasibility study due later this year, potentially bolstering future prospects in the graphite market.

ASX:SVM Financial Position Analysis as at Apr 2025
ASX:SVM Financial Position Analysis as at Apr 2025

Southern Cross Media Group (ASX:SXL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Southern Cross Media Group Limited, with a market cap of A$165.53 million, creates audio content for distribution across broadcast and digital networks in Australia.

Operations: The company generates revenue through its Digital Audio segment, contributing A$41.57 million, and its Broadcast Radio segment, bringing in A$370.70 million.

Market Cap: A$165.53M

Southern Cross Media Group, with a market cap of A$165.53 million, faces challenges despite generating significant revenue from its Digital Audio and Broadcast Radio segments. Recent events include its removal from the S&P/ASX All Ordinaries Index and a decision to halt dividends to focus on debt reduction. The company remains unprofitable with negative return on equity but has managed to reduce its debt-to-equity ratio over five years. While short-term liabilities are covered by assets, long-term liabilities remain uncovered. Leadership changes aim to strengthen financial oversight as earnings are forecasted to grow significantly in the coming years.

ASX:SXL Financial Position Analysis as at Apr 2025
ASX:SXL Financial Position Analysis as at Apr 2025

Seize The Opportunity

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About ASX:DXB

Dimerix

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Mediocre balance sheet and slightly overvalued.

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4342.5% undervalued
30 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7829.0% undervalued
32 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative
ST
WBD logo
SteveGruber on Warner Bros. Discovery ·

The Rising Deal Risk That Helped Sink Netflix’s $72 Billion Bid for Warner Bros. Discovery  

Fair Value:US$18.1752.7% overvalued
5 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6435.3% undervalued
35 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative

Updated Narratives

VE
Vestra
KTOS logo
Vestra on Kratos Defense & Security Solutions ·

Kratos Defense & Security Solutions (KTOS): Scaling "Attritable" Dominance in a New Era of Aerial Conflict.

Fair Value:US$11821.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
BWXT logo
Vestra on BWX Technologies ·

BWX Technologies (BWXT): Powering the Nuclear Renaissance from Naval Depths to Medical Frontiers.

Fair Value:US$205.22.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
MRK logo
Vestra on Merck ·

Merck & Co. (MRK): Scaling the "Post-Keytruda Hill" Through Diversified Blockbusters.

Fair Value:US$144.4818.9% undervalued
10 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.377.2% undervalued
51 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59631.3% undervalued
1303 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.8% undervalued
1102 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative